With personalized care, medical expertise, and advanced treatments, clients experience noticeable results and enhanced wellbeing.
Semaglutide causes weight loss by directly interacting with the glucagon hormonal system, which is tied to hunger, satiation, and blood sugar management
Hayreh SS
Current law prohibits Medicare from covering obesity drugs and gives states flexibility to cover weight loss drugs under Medicaid Limitations on coverage for obesity drugs in Medicare and Medicaid mean that millions of people who have obesity and might benefit from taking GLP-1s may be unable to access them unless they are able to pay the full cash price out of their own pockets, which would likely be prohibitive for people with Medicaid who must have low incomes to qualify for the program, as well as for many people on Medicare with low and modest incomes
We also provide hormone optimization, metabolic testing, nutrition planning, and telemedicine follow-ups
If you gain the weight back, it comes back as fat